Interpace Biosciences, Inc.
IDXG
$0.9077
-$0.0823-8.31%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -138.86% | -43.05% | 125.94% | -47.48% | 244.21% |
| Total Depreciation and Amortization | 4.74% | -9.95% | 11.64% | 0.53% | 17.50% |
| Total Amortization of Deferred Charges | 36.36% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,240.00% | -104.02% | -49.60% | 6,957.14% | -94.26% |
| Change in Net Operating Assets | 221.39% | 72.19% | -1,516.99% | 112.46% | -17.18% |
| Cash from Operations | -57.89% | 4.31% | -44.05% | 50.71% | 2,520.69% |
| Capital Expenditure | -- | -- | 75.29% | -164.97% | -603.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 75.29% | -164.97% | -603.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | 0.00% | 0.00% | 25.00% | -233.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.47% | 12.13% | -13.80% | 25.00% | -233.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.89% | 59.36% | -793.62% | 111.85% | -15.60% |